YOLFTbeta
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.

605016 · SHG · Consumer Defensive / Packaged Foods

20.50CNY+0.57 (+2.86%)

Price History

Full chart

Market Stats

Previous Close19.93
Open20.14
Day Range19.76 – 20.58
52-Week Range18.52 – 28.81
Volume7.87M
Market Cap8.87B
P/E (TTM)21.54
Forward P/E0.00
EPS0.98
Dividend Yield1.37%
Beta0.26
50-Day Avg21.08
200-Day Avg23.74

About

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltitol, organic maltodextrin, allulose psicose, isomalt, and isomaltulose, as well as allulose powder and maltitol syrups. The company sells its products to manufacturers, traders, and retail customers of food, beverages, dairy products, health products, pharmaceuticals, animal nutrition, and feed sectors. Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. was founded in 2005 and is based in Yucheng, China.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Hongjian Zhuo
  • Employees990
  • HeadquartersNational High-tech Industrial Development Zone, Yucheng, China, 251200, China
  • Websitehttps://www.sdblcy.com

Leadership

  • Mr. Hongjian ZhuoGeneral Manager · b. 1978
  • Ms. Li LiChief Financial Officer · b. 1978
  • Mr. Junchao GuBoard Secretary · b. 1988
  • Mr. Anguo ZhangDeputy General Manager · b. 1969
  • Mr. Guangpeng DouDeputy General Manager · b. 1983
  • Mr. Dexuan ZhaoDeputy General Manager · b. 1982
  • Mr. Wenping YuDeputy General Manager · b. 1986
  • Mingjing ShangAccounting Supervisor

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue335.52M310.61M355.53M421.05M499.62M653.36M721.89M868.26M1.15B1.38B
Growth (%)--7.43%+14.46%+18.43%+18.66%+30.77%+10.49%+20.28%+32.64%+19.75%
Cost of Revenue209.22M191.72M234.89M262.31M336.39M471.72M493.41M584.20M764.89M803.18M
Gross Profit126.30M118.89M120.64M158.74M163.23M181.64M228.49M284.06M386.76M575.87M
Gross Margin37.64%38.28%33.93%37.70%32.67%27.80%31.65%32.72%33.58%41.76%
Operating Expense52.71M43.05M43.01M60.01M52.48M61.39M52.00M60.37M101.63M127.37M
Operating Income73.59M75.84M77.64M98.73M110.75M120.25M176.48M223.69M285.13M448.50M
Operating Margin21.93%24.42%21.84%23.45%22.17%18.40%24.45%25.76%24.76%32.52%
EBITDA111.54M105.74M99.66M124.59M150.38M156.51M192.42M238.38M334.22M536.86M
EBITDA Margin33.24%34.04%28.03%29.59%30.10%23.95%26.65%27.46%29.02%38.93%
Net Income64.80M63.73M65.30M82.78M95.55M104.48M150.75M193.00M245.60M368.55M
Net Income Margin19.31%20.52%18.37%19.66%19.12%15.99%20.88%22.23%21.33%26.72%
R&D10.61M10.36M11.08M15.02M15.37M23.26M27.03M32.56M44.46M48.82M
R&D as % of Total Revenue3.16%3.33%3.12%3.57%3.08%3.56%3.74%3.75%3.86%3.54%
Interest Expense19.09M3.83M4.57M2.50M4.38M1.18M196.69K2.43M2.92M5.77M
Interest Expense % of Total Revenue5.69%1.23%1.28%0.59%0.88%0.18%0.03%0.28%0.25%0.42%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets631.82M625.78M609.80M754.35M836.00M1.28B1.47B1.75B2.01B2.44B
Total Liabilities269.14M189.38M108.09M157.28M144.91M79.05M126.99M246.35M334.27M475.19M
Total Equity362.67M436.41M501.71M597.07M691.09M1.20B1.34B1.51B1.68B1.96B
Cash166.82M175.96M91.02M84.52M141.36M305.24M191.69M175.87M286.84M501.70M
Total Debt208.07M138.00M55.90M53.90M68.50M2.52M1.45M627.32K11.02M-
Net Debt41.25M-37.96M-35.12M-30.62M-72.86M-302.73M-190.24M-174.21M-275.82M-

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow60.10M113.47M89.12M64.08M121.82M96.20M149.82M194.63M300.89M135.45M
Investing Cash Flow79.30M-45.14M-81.26M-73.89M-38.25M-297.69M-246.90M-223.72M-172.89M-
Financing Cash Flow5.60M-69.10M-87.05M-9.82M-9.00M362.36M-13.07M-34.12M-70.35M-
Capital Expenditure28.08M36.66M88.11M56.49M58.66M55.82M175.60M311.98M281.81M296.80M
Free Cash Flow32.02M76.81M1.01M7.59M63.16M40.38M-25.78M-117.34M19.09M-161.35M
Dividends Paid17.99M8.43M4.50M2.37M4.21M1.34M10.78M32.34M77.99M92.82M
FCF to OCF53.28%67.69%1.13%11.85%51.85%41.98%-17.21%-60.29%6.34%-119.12%
Dividend Paid to FCF56.16%10.98%445.32%31.27%6.67%3.31%-41.80%-27.56%408.63%-57.53%

Earnings

Report DateJun 30, 2021Sep 30, 2021Mar 2, 2022Apr 9, 2022Jul 21, 2022Oct 13, 2022Mar 12, 2023Apr 27, 2023Aug 3, 2023Oct 20, 2023Feb 27, 2024Mar 31, 2024Jul 9, 2024Oct 30, 2024Dec 31, 2024Apr 29, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------
EPS Actual0.080.060.170.230.210.220.180.180.140.160.160.130.200.200.150.250.210.230.250.290.21
Surprise---------------------
Timing--After-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-market-----

Key Statistics & Ratios

Market Cap8.87B
Enterprise Value8.86B
Trailing P/E21.54
Forward P/E0.00
Price / Sales5.95
Price / Book4.30
EPS0.98
Book Value5.01
Revenue (TTM)1.49B
Gross Profit (TTM)639.73M
EBITDA582.29M
Profit Margin27.49%
Operating Margin31.79%
Return on Equity20.96%
Return on Assets11.74%
Shares Outstanding420.01M
Shares Float192.57M
Beta0.26
Dividend Yield1.37%
Dividend Rate0.29
Payout Ratio29.75%

Dividends

20261×
0.17Jun 2, 2026
20253×
0.05Dec 12, 20250.05Sep 12, 20250.11Jun 11, 2025
20243×
0.02Dec 27, 20240.02Sep 13, 20240.18Jun 6, 2024
20231×
0.10Jun 1, 2023
20221×
0.04Jul 1, 2022

Stock Splits

  • Jun 11, 20251.3:1
  • Jun 6, 20241.3:1
  • Jun 1, 20231.4:1
  • Jul 1, 20221.4:1